ArticleFrontiers in aging neuroscience2018
Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [
Abstract read
In one paragraph
Article in Frontiers in aging neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The genetic landscape of neuro-related proteins in human plasma.Nature human behaviour · 2024Pooled it
- Inflammatory proteins associated with Alzheimer's disease reduced by a GLP1 receptor agonist: a post hoc analysis of the EXSCEL randomized placebo controlled trial.Alzheimer's research & therapy · 2024Trial
- HDL-Apolipoprotein in Alzheimer's Disease Revisited: From Periphery to CNS.Aging medicine (Milton (N.S.W)) · 2025Review
- Integrating amyloid and tau imaging with proteomics and genomics in Alzheimer's disease.Cell reports. Medicine · 2024Review
- Amyloid fibril proteomics of AD brains reveals modifiers of aggregation and toxicity.Molecular neurodegeneration · 2023Article
- Genetic mechanisms of 184 neuro-related proteins in human plasma.medRxiv : the preprint server for health sciences · 2023Article
- Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer's disease: results from the DELCODE study.Alzheimer's research & therapy · 2023Article
- Omics-based biomarkers discovery for Alzheimer's disease.Cellular and molecular life sciences : CMLS · 2022Review
- Plasma proteome profiling identifies changes associated to AD but not to FTD.Acta neuropathologica communications · 2022Article
- Apolipoprotein A1, the neglected relative of Apolipoprotein E and its potential role in Alzheimer's disease.Neural regeneration research · 2021Review
- Persistence of Lipoproteins and Cholesterol Alterations after Sepsis: Implication for Atherosclerosis Progression.International journal of molecular sciences · 2021Review
- The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers.European journal of nuclear medicine and molecular imaging · 2021Review
- A multicentre validation study of the diagnostic value of plasma neurofilament light.Nature communications · 2021Article
- Detection of β-amyloid positivity in Alzheimer's Disease Neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkers.Brain communications · 2021Article
- Plasma Proteomic Biomarkers Relating to Alzheimer's Disease: A Meta-Analysis Based on Our Own Studies.Frontiers in aging neuroscience · 2021Article
- Serum albumin and beta-amyloid deposition in the human brain.Neurology · 2020Article
- Cerebrospinal fluid ceruloplasmin levels predict cognitive decline and brain atrophy in people with underlying β-amyloid pathology.Neurobiology of disease · 2020Observational
- An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders.Nature reviews. Neurology · 2020Review
- Human Plasma Protein Corona of Aβ Amyloid and Its Impact on Islet Amyloid Polypeptide Cross-Seeding.Biomacromolecules · 2020Article
- Differential Expression of mRNAs in Peripheral Blood Related to Prodrome and Progression of Alzheimer's Disease.BioMed research international · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Sarah WestwoodDepartment of Psychiatry, University of Oxford, Oxford, United Kingdom.
Alison L BairdDepartment of Psychiatry, University of Oxford, Oxford, United Kingdom.
Abdul HyeMaurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kigndom.
Nicholas J AshtonMaurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kigndom.
Alejo J Nevado-HolgadoDepartment of Psychiatry, University of Oxford, Oxford, United Kingdom.
Sneha N AnandDepartment of Psychiatry, University of Oxford, Oxford, United Kingdom.
Benjamine LiuDepartment of Psychiatry, University of Oxford, Oxford, United Kingdom.
Danielle NewbyDepartment of Psychiatry, University of Oxford, Oxford, United Kingdom.
Chantal BazenetMaurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kigndom.
Steven J KiddleDepartment of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.
Malcolm WardProteomics Facility, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.
Ben NewtonGE Healthcare Life Sciences Core Imaging, London, United Kingdom.
Keyur DesaiBiosciences, GE Global Research, Niskayuna, NY, United States.
Cristina Tan HehirBiosciences, GE Global Research, Niskayuna, NY, United States.
Michelle ZanetteGE Healthcare Life Sciences Core Imaging, Marlborough, MA, United States.
Daniela GalimbertiNeurodegenerative Diseases Unit, Centro Dino Ferrari, University of Milan, Milan, Italy.
Lucilla ParnettiCenter for Memory Disorders and Laboratory of Clinical Neurochemistry, Neurology Clinic, University of Perugia, Perugia, Italy.
Alberto LleóDepartment of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
Susan BakerJanssen Neuroscience Research & Development, Titusville, NJ, United States.
Vaibhav A NarayanJanssen Neuroscience Research & Development, Titusville, NJ, United States.
Wiesje M van der FlierDepartment of Neurology, Alzheimer Centre, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, Netherlands.
Philip ScheltensDepartment of Neurology, Alzheimer Centre, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, Netherlands.
Charlotte E TeunissenDepartment of Clinical Chemistry, Neurochemistry Lab and Biobank, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, Netherlands.
Pieter Jelle VisserDepartment of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands.
Simon LovestoneDepartment of Psychiatry, University of Oxford, Oxford, United Kingdom.
Funding
Medical Research Council MC_PC_17215Medical Research Council MR/L011859/1Medical Research Council MR/P021573/1
Abstract
PubMed holds no abstract for this paper.
Indexed as
Alzheimer’s diseaseamyloidbiomarkersbloodficolin-2plasmaproteomicstau
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.